InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Quinlan Amy. Officer active across 1 company, notably Vor Biopharma Inc.. Aggregated, 3 reports have been logged. History available since 1 August 2024. The latest transaction was filed on 6 November 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
3 of 3 declarations